Vical (VICL +0.7%) trades in the green today after being initiated at Brinson Patrick with an...

|About: Vical Incorporated (VICL)|By:, SA News Editor

Vical (VICL +0.7%) trades in the green today after being initiated at Brinson Patrick with an Outperform and a price target of $7 a share. The firm says that Allovectin is poised to be a significant value driver for the company, beginning in Q2 with a database lock of its melanoma Phase III trial. They believe the results will be positive, which will position VICL with a blockbuster opportunity in the melanoma market.